CC

CAXTON CORP

13F
CAXTON CORP
Last update 2025-02-16 15 Stocks (4 new)
Value $17.00 Mil Turnover 3 %
Countries:
Top Holdings: XERS(41.06%)RZLT(38.85%)SPY(9.94%)BRK.B(3.09%)GLD(1.70%)
Summary Stock Picks Current Portfolio
CAXTON CORP Top Holdings of 2024-12-31 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
XERS 		Xeris Biopharma Holdings Inc
2,015,157
6,831.4
-60.59%
41.060
-36.54%
1.350
+28.72%
+27.58%
665.8
Biotechnology
RZLT 		Rezolute Inc
1,318,967
6,462.9
0%
38.850
0%
2.180
-47.98%
-44.69%
164.1
Biotechnology
SPY 		SPDR S&P 500 ETF Trust
2,823
1,654.5
-1.53%
9.940
-0.10%
0.000
-6.65%
-6.11%
555,961.7
 
BRK.B 		Berkshire Hathaway Inc
1,133
513.5
-1.56%
3.090
-0.03%
0.000
+15.40%
+15.03%
1,122,843.1
Insurance
GLD 		SPDR Gold Shares ETF
1,169
283.1
New Holding
1.700
+1.70%
0.000
+16.07%
+17.86%
92,777.0
 
MNMD 		Mind Medicine Inc
34,073
237.2
0%
1.430
0%
0.050
-19.67%
-18.41%
428.0
Biotechnology
BCAX 		Bicara Therapeutics Inc
10,941
190.6
0%
1.150
0%
0.020
-32.00%
-40.47%
565.4
Biotechnology
LXEO 		Lexeo Therapeutics Inc
17,851
117.5
0%
0.710
0%
0.050
-65.40%
-64.13%
78.3
Biotechnology
KYTX 		Kyverna Therapeutics Inc
22,981
86.0
0%
0.520
0%
0.050
-49.21%
-48.40%
83.4
Biotechnology
CMPX 		Compass Therapeutics Inc
43,465
63.0
0%
0.380
0%
0.030
-6.18%
+20.34%
241.3
Biotechnology

CAXTON CORP's Historical Top Holdings Breakdowns

CAXTON CORP's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
XERS 		Xeris Biopharma Holdings Inc2024-12-31Reduce
-36.54%
●
2.78 ($3.22) 3.73
$4.33
34.32%
Reduce -60.59%
2,015,157
-3,098,191
GLD 		SPDR Gold Shares ETF2024-12-31New Buy
+1.70%
●
236.59 ($245.74) 257.5
$285.38
16.13%
New holding
1,169
1,169
ABVX 		Abivax SA2024-12-31Sold Out
-0.54%
●
7.05 ($9.18) 10.69
$5.85
-36.27%
Sold Out
0
-11,365
CRDF 		Cardiff Oncology Inc2024-12-31New Buy
+0.35%
●
2.31 ($3.14) 5.35
$2.59
-17.52%
New holding
13,287
13,287
IKT 		Inhibikase Therapeutics Inc2024-12-31New Buy
+0.32%
●
1.19 ($2.51) 3.97
$1.88
-25.10%
New holding
16,393
16,393
GLYC 		GlycoMimetics Inc2024-12-31New Buy
+0.31%
●
0.14 ($0.27) 0.49
$0.19
-28.81%
New holding
203,578
203,578
SPY 		SPDR S&P 500 ETF Trust2024-12-31Reduce
-0.10%
●
567.8 ($589.49) 607.81
$548.62
-6.93%
Reduce -1.53%
2,823
-44
BRK.B 		Berkshire Hathaway Inc2024-12-31Reduce
-0.03%
●
442.29 ($461.8) 483.08
$521.41
12.91%
Reduce -1.56%
1,133
-18
SPY 		SPDR S&P 500 ETF Trust2024-09-30Add
+2.37%
●
517.38 ($552.93) 573.76
$548.62
-0.78%
Add 53.4%
2,867
998
BCAX 		Bicara Therapeutics Inc2024-09-30New Buy
+1.15%
●
23.41 ($25.5) 27.07
$10.37
-59.33%
New holding
10,941
10,941

CAXTON CORP Total Holding History ($B)

To

CAXTON CORP's Asset Allocation

To

CAXTON CORP Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

CAXTON CORP's Hypothetical Growth since 2024-12-31

CAXTON CORP's Yearly Returns

Year Portfolio % % Excess Gain %

CAXTON CORP's Holdings Heat Map

Size field:

CAXTON CORP's Holdings Bubble Chart

CAXTON CORP News

  • 1

Discussions on CAXTON CORP

No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.